Oriola Oyj Series B
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and resea… Read more
Market Cap & Net Worth: Oriola Oyj Series B (0NES)
Oriola Oyj Series B (LSE:0NES) has a market capitalization of $184.32 Million (€179.57 Million) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #16688 globally and #324 in its home market, demonstrating a -1.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oriola Oyj Series B's stock price €0.99 by its total outstanding shares 181382000 (181.38 Million).
Oriola Oyj Series B Market Cap History: 2026 to 2026
Oriola Oyj Series B's market capitalization history from 2026 to 2026. Data shows growth from $184.32 Million to $184.32 Million (0.00% CAGR).
Oriola Oyj Series B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oriola Oyj Series B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0NES by Market Capitalization
Companies near Oriola Oyj Series B in the global market cap rankings as of March 19, 2026.
Key companies related to Oriola Oyj Series B by market ranking:
- Healwell AI Inc. (OTCQX:HWAIF): Ranked #16679 globally with a market cap of $142.74 Million USD.
- Franbo Lines (TWO:2641): Ranked #16680 globally with a market cap of $142.71 Million USD ( NT$4.72 Billion TWD).
- Feedback Technology (TWO:8091): Ranked #16689 globally with a market cap of $142.49 Million USD ( NT$4.71 Billion TWD).
- BEISEN HLDG LTD (F:U8V): Ranked #16690 globally with a market cap of $142.46 Million USD ( €138.79 Million EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16679 | Healwell AI Inc. | OTCQX:HWAIF | $142.74 Million | $0.95 |
| #16680 | Franbo Lines | TWO:2641 | $142.71 Million | NT$18.70 |
| #16689 | Feedback Technology | TWO:8091 | $142.49 Million | NT$135.50 |
| #16690 | BEISEN HLDG LTD | F:U8V | $142.46 Million | €0.49 |
Oriola Oyj Series B Historical Marketcap From 2026 to 2026
Between 2026 and today, Oriola Oyj Series B's market cap moved from $184.32 Million to $ 184.32 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €184.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Oriola Oyj Series B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $184.32 Million USD |
| MoneyControl | $184.32 Million USD |
| MarketWatch | $184.32 Million USD |
| marketcap.company | $184.32 Million USD |
| Reuters | $184.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.